Dr. Reddy's Plans To Match Global Generics Achievement With Biosimilars
This article was originally published in PharmAsia News
Executive Summary
Dr. Reddy's Laboratories plans to take advantage of its success with marketing biosimilars in emerging markets and expand to developed markets, according to the company's annual report covering the recent fiscal year.